{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:39:26Z","timestamp":1793338766367,"version":"4.5.0"},"reference-count":51,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["18-016-00159"],"award-info":[{"award-number":["18-016-00159"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The recent progress in immunoinformatics provided the basis for an accelerated development of target-specific peptide vaccines as an alternative to the traditional vaccine concept. However, there is still limited information on whether the in silico predicted immunoreactive epitopes correspond to those obtained from the actual experiments. Here, humoral and cellular immune responses to two major Yersinia pestis protective antigens, F1 and LcrV, were studied in human donors immunized with the live plague vaccine (LPV) based on the attenuated Y. pestis strain EV line NIIEG. The F1 antigen provided modest specific cellular (mixed T helper 1 (Th1)\/Th2 type) and humoral immune responses in vaccinees irrespective of the amount of annual vaccinations and duration of the post-vaccination period. The probing of the F1 overlapping peptide library with the F1-positive sera revealed the presence of seven linear B cell epitopes, which were all also predicted by in silico assay. The immunoinformatics study evaluated their antigenicity, toxicity, and allergenic properties. The epitope TSQDGNNH was mostly recognized by the sera from recently vaccinated donors rather than antibodies from those immunized decades ago, suggesting the usefulness of this peptide for differentiation between recent and long-term vaccinations. The in silico analysis predicted nine linear LcrV-specific B-cell epitopes; however, weak antibody and cellular immune responses prevented their experimental evaluation, indicating that LcrV is a poor marker of successful vaccination. No specific Th17 immune response to either F1 or LcrV was detected, and there were no detectable serum levels of F1-specific immunoglobulin A (IgA) in vaccinees. Overall, the general approach validated in the LPV model could be valuable for the rational design of vaccines against other neglected and novel emerging infections with high pandemic potency.<\/jats:p>","DOI":"10.3390\/vaccines8040698","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T10:46:26Z","timestamp":1605782786000},"page":"698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine\u2014Comparison of Immunoinformatic and Immunological Approaches"],"prefix":"10.3390","volume":"8","author":[{"given":"Valentina A.","family":"Feodorova","sequence":"first","affiliation":[{"name":"Laboratory for Molecular Biology and NanoBiotechnology, Federal Research Center for Virology and Microbiology, Branch in Saratov, 410028 Saratov, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Lyapina","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Biology and NanoBiotechnology, Federal Research Center for Virology and Microbiology, Branch in Saratov, 410028 Saratov, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7053-8322","authenticated-orcid":false,"given":"Maria A.","family":"Khizhnyakova","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Biology and NanoBiotechnology, Federal Research Center for Virology and Microbiology, Branch in Saratov, 410028 Saratov, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey S.","family":"Zaitsev","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Biology and NanoBiotechnology, Federal Research Center for Virology and Microbiology, Branch in Saratov, 410028 Saratov, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury V.","family":"Saltykov","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Biology and NanoBiotechnology, Federal Research Center for Virology and Microbiology, Branch in Saratov, 410028 Saratov, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir L.","family":"Motin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fimmu.2020.00442","article-title":"Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools","volume":"11","author":"Moise","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Korber, B.T., Labute, M., and Yusim, K. (2006). Immunoinformatics Comes of Age. PLoS Comput. Biol., 2.","DOI":"10.1371\/journal.pcbi.0020071"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/S0264-410X(01)00145-1","article-title":"From genome to vaccine: In silico predictions, ex vivo verification","volume":"19","author":"Bosma","year":"2001","journal-title":"Vaccine"},{"key":"ref_5","first-page":"108","article-title":"Multi-Epitope Cluster Ep85B within the Mycobacterial Protein Ag85B Elicits Cell-Mediated and Humoral Responses in Mice","volume":"6","author":"Islam","year":"2018","journal-title":"Turk. J. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.82","article-title":"Russian vaccines against especially dangerous bacterial pathogens","volume":"3","author":"Feodorova","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2012.34","article-title":"Plague vaccines: Current developments and future perspectives","volume":"1","author":"Feodorova","year":"2012","journal-title":"Emerg. Microbes Infect."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gallagher, T.B., Mellado-S\u00e1nchez, G., Jorgensen, A.L., Moore, S., Nataro, J.P., Pasetti, M.F., and Baillie, L. (2019). Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007644"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/IAI.00296-19","article-title":"A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice","volume":"87","author":"Singh","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_10","first-page":"499","article-title":"Highly Effective Soluble and Bacteriophage T4 Nanoparticle Plague Vaccines Against Yersinia pestis","volume":"1403","author":"Tao","year":"2016","journal-title":"Breast Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Batra, L., Verma, S.K., Nagar, D.P., Saxena, N., Pathak, P., Pant, S.C., and Tuteja, U. (2014). HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003322"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/iai.63.8.3021-3029.1995","article-title":"Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization","volume":"63","author":"Nakajima","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2018.06.039","article-title":"Dual route vaccination for plague with emergency use applications","volume":"36","author":"Moore","year":"2018","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/CVI.00150-16","article-title":"A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates","volume":"23","author":"Sha","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates","volume":"16","author":"Mizel","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1016\/j.vaccine.2017.05.092","article-title":"Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague","volume":"35","author":"Zvi","year":"2017","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1574-695X.2000.tb01426.x","article-title":"Identification of immunodominant epitope of F1 antigen of Yersinia pestis","volume":"27","author":"Sabhnani","year":"2000","journal-title":"FEMS Immunol. Med Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/IAI.00195-10","article-title":"Repertoire of HLA-DR1-Restricted CD4 T-Cell Responses to Capsular Caf1 Antigen of Yersinia pestis in Human Leukocyte Antigen Transgenic Mice","volume":"78","author":"Musson","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0928-8244(03)00170-6","article-title":"Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles","volume":"38","author":"Sabhnani","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Braciale, V.L., Nash, M., Sinha, N., Zudina, I.V., and Motin, V.L. (2008). Correlates of Immunity Elicited by Live Yersinia pestis Vaccine. National Institute of Allergy and Infectious Diseases, NIH, Humana Press.","DOI":"10.1007\/978-1-59745-569-5_50"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Feodorova, V.A., Lyapina, A.M., Khizhnyakova, M.A., Zaitsev, S.S., Sayapina, L.V., Arseneva, T.E., Trukhachev, A.L., Lebedeva, S.A., Telepnev, M.V., and Ulianova, O.V. (2018). Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006511"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ponomarenko, J.V., Bui, H.-H., Li, W., Fusseder, N., Bourne, P.E., Sette, A., and Peters, B. (2008). ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-514"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., and Raghava, G.P.S. (2013). Open Source Drug Discovery Consortium In Silico Approach for Predicting Toxicity of Peptides and Proteins. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073957"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Doytchinova, I., and Flower, D.R. (2007). VAXIJN: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-4"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"W72","DOI":"10.1093\/nar\/gki396","article-title":"SCRATCH: A protein structure and structural feature prediction server","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Corbel","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect Immun"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/CVI.05559-11","article-title":"Humoral and Cellular Immune Responses to Yersinia pestis Infection in Long-Term Recovered Plague Patients","volume":"19","author":"Li","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_31","first-page":"39","article-title":"The serological response to Yersinia pestis infection","volume":"55","author":"Butler","year":"1977","journal-title":"Bull. World Heal. Organ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/IAI.73.6.3734-3739.2005","article-title":"Protein Microarray for Profiling Antibody Responses to Yersinia pestis Live Vaccine","volume":"73","author":"Li","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.vaccine.2006.01.031","article-title":"Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery","volume":"24","author":"Tripathi","year":"2006","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Xiao, X., Zhu, Z., Dankmeyer, J.L., Wormald, M.M., Fast, R.L., Worsham, P.L., Cote, C.K., Amemiya, K., and Dimitrov, D.S. (2010). Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013047"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/sji.12042","article-title":"Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model","volume":"77","author":"Ali","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Liu, W., Ren, J., Zhang, J., Song, X., Liu, S., Chi, X., Chen, Y., Wen, Z., Li, J., and Chen, W. (2017). Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177012"},{"key":"ref_37","unstructured":"Devdariani, Z.L., A Fedorova, V., Gromova, O.V., and Taranenko, T.M. (1997). Comparative incidence of detection of specific antibodies to Yersinia pestis capsular antigen and lipopolysaccharide in humans immunized with pest vaccine. Klin. Lab. Diagn., 39\u201341."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective Efficacy of Recombinant Yersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis","volume":"67","author":"Andrews","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/IAI.00242-09","article-title":"High-Throughput Identification of New Protective Antigens from a Yersinia pestis Live Vaccine by Enzyme-Linked Immunospot Assay","volume":"77","author":"Li","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2017.09.070","article-title":"A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin\/F1\/V, in healthy adult volunteers (DMID 08-0066)","volume":"35","author":"Frey","year":"2017","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41541-020-0156-y","article-title":"Flagellin adjuvanted F1\/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures","volume":"5","author":"Hamzabegovic","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/IAI.00105-08","article-title":"Yersinia pestis caf1 Variants and the Limits of Plague Vaccine Protection","volume":"76","author":"Quenee","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.vaccine.2018.11.022","article-title":"Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine","volume":"37","author":"Demeure","year":"2019","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/CVI.00305-09","article-title":"Long-Term Observation of Subunit Vaccine F1-rV270 against Yersinia pestis in Mice","volume":"17","author":"Wang","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1016\/j.vaccine.2016.09.060","article-title":"Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis","volume":"34","author":"Daniel","year":"2016","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.vaccine.2016.03.094","article-title":"Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague","volume":"34","author":"Sanapala","year":"2016","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.vaccine.2016.09.063","article-title":"Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague","volume":"34","author":"Arnaboldi","year":"2016","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/mpat.1997.0141","article-title":"Expression of an F1\/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague","volume":"23","author":"Leary","year":"1997","journal-title":"Microb. Pathog."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1016\/j.vaccine.2011.09.129","article-title":"Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice","volume":"29","author":"Uppada","year":"2011","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2007.11.028","article-title":"Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis","volume":"26","author":"Khan","year":"2008","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/IAI.66.2.521-527.1998","article-title":"Analysis of the Yersinia pestis V Protein for the Presence of Linear Antibody Epitopes","volume":"66","author":"Pullen","year":"1998","journal-title":"Infect. Immun."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/698\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:32Z","timestamp":1760178872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["vaccines8040698"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8040698","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]}}}